# Neuralink — Healthcare Investment Intelligence

> other · Series B. MedFuel Intel profile as of 2026-06-12.

Neuralink is an American neurotechnology company developing implantable brain-computer interfaces (BCIs) founded by Elon Musk in 2016.[1][5] It has received FDA approval for clinical trials as of May 2023 and implanted devices in patients by 2024, enabling control of computers and games via thought.[2][5]

## Key facts (as of 2026-06-12)
- Sector: other
- Stage: Series B
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 15/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-4. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.